TRVN:OTCMKTS
Trevena Inc
0,012Â US$
0,00%
(0,00) 1D
6. okt., 10.01.51 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for TRVN...
Markedsværdi
10,37Â t
Gns. vol.
223,00
Volumen
19,00
Højeste i 52 uger
1,50Â US$
Laveste i 52 uger
0,00Â US$
Beta
1,07
Aktier i omløb
864,00Â t
Antal ansatte
23
Markedsværdi
10,37Â t
Gns. vol.
223,00
Volumen
19,00
Højeste i 52 uger
1,50Â US$
Laveste i 52 uger
0,00Â US$
Beta
1,07
Aktier i omløb
864,00Â t
Antal ansatte
23
Nyhedshistorier
Fra webkilder og nyhedspartnere
Invezz
·
for 2 dage siden
Dow åbner 400 point lavere, da olie og Treasury-renter stiger før Fed-referatet
Invezz
·
for 1 dag siden
Dow åbner 120 point lavere, da olie stiger og statsrenter forbliver høje
Invezz
·
for 1 dag siden
Dow falder 340 point, stigende Treasury-renter genopvækker frygt for rentehævninger
Traders Union
·
for 2 dage siden
Amerikanske aktiefutures svækkes efter rekordlukning for S&P 500
Profil
Trevena, Inc. is a clinical stage biopharmaceutical company, headquartered in Chesterbrook, Pennsylvania, USA, and is involved in the discovery and development of G-protein coupled receptors biased ligands. Trevena was founded in 2007 with technology licensed from Duke University, which originated in the labs of company founders Robert Lefkowitz winner of the 2012 Nobel Prize in Chemistry and Howard Rockman. Trevena's approach to drug discovery is based on utilizing ligand bias, or functional selectivity, at GPCR targets to produce drugs with improved efficacy and reduced side effect profiles. Trevena was named one of the top 15 US startups of 2008 by Business Week.
Trevena's expertise lies in engineering "biased ligands" that activate only the beneficial signaling pathways downstream of a GPCR to unlock new biology and avoid drug adverse effects. Trevena's pipeline currently includes a clinical stage mu-opioid biased ligand for post-operative pain, and discovery-stage programs for chronic pain, migraine, and Parkinson's disease. Wikipedia
Om Trevena Inc
Administrerende direktør-
Ansatte23
Grundlagt2007
HovedsædeAtlanta, Georgia, USA
Sektor-
Websitetrevena.com